If the agency’s commissioner signs off on the recommendation and the data passes CDC inspection, children could sport Moderna on their vaccine cards as early as next week, according to USA Today.
The decision comes months after the Pfizer-BioNTech vaccine was authorized for 6-year-olds and up, and about four weeks after the FDA authorized Pfizer’s booster shot for children 5 to 11.
Current CDC data reports 71 percent of 5- to 11-year-olds and 75.2 percent of 12- to 17-year-olds are fully vaccinated against COVID-19.
The FDA is meeting June 15 to deliberate on Moderna’s vaccine for 5- to 11-year-olds. The latest data, which was pre-omicron, shows the vaccine to be “safe and effective” with an efficacy rate of 77 percent for 6- to 11-year-olds and 93 percent for 12- to 17-year-olds, according to Politico.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
